Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: Meta-analysis of randomized controlled trials

Canadian Family Physician

Volumn 55, Issue 1, 2009, Pages 60-67

  Korbila, Ioanna P ^a   Manta, Katerina G ^a   Siempos, Ilias I ^a   Dimopoulos, George ^a,b   Falagas, Matthew E ^a,c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; COTRIMAZINE; COTRIMOXAZOLE; MIRAXID; PENICILLIN DERIVATIVE; PIVAMPICILLIN; TRIMETHOPRIM; TRIMETHOPRIM DERIVATIVE;

ARTICLE; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA SYNTHESIS; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; META ANALYSIS; MONOTHERAPY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ACUTE DISEASE; AMOXICILLIN; ANTI-INFECTIVE AGENTS; BRONCHITIS, CHRONIC; DRUG THERAPY, COMBINATION; HUMANS; PIVAMPICILLIN; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 58949088859     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes NC. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;(2):CD004403.
2. Balter MS, La Forge J, Low DE, Mandell L, Grossman RF; Canadian Thoracic Society; Canadian Infectious Disease Society. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J 2003;10(Suppl B):3B-32B.
3. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26(6):1138-80. Erratum in: Eur Respir J 2006;27(2):439.
4. Siempos II, Dimopoulos G, Korbila IP, Manta K, Falagas ME. Macrolides, quinolones, and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis. Eur Respir J 2007;29(3):548-60.
5. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17(1):1-12.
6. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004;23(11):1663-82.
7. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
8. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22(4):719-48.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-88.
10. Sachs AP, Koeter GH, Groenier KH, van der Waaij D, Schiphuis J, Meyboomde Jong B. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 1995;50(7):758-63.
11. Gove RI, Cayton RM. A double-blind comparison of amoxycillin with trimethoprim in acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1985;15(4):495-9.
12. Lal S, McGhie D, Kerfoot P. A comparison of pivmecillinam/pivampicillin and co-trimoxazole in hospitalised patients with acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1984;14(2):179-84.
13. Leone G, Lanza R, Paoletti V, Parlapiano C, Vincentelli GM. A clinical trial of co-trimazine (sulfadiazine + trimethoprim) in flare-ups of chronic bronchitis. J Int Med Res 1984;12(1):1-9.
14. Pines A, Nandi AR, Raafat H, Rahman M. Amoxycillin and co-trimoxazole in acute purulent exacerbations of chronic bronchitis. Chemotherapy 1977;23(1):58-64.
15. Ulmer WT, Zimmermann I. A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis. J Int Med Res 1981;9(5):372-7.
16. De Vlieger A, Druart M, Puttemans M. Roxithromycin versus doxycycline in the treatment of acute exacerbations of chronic bronchitis. Diagn Microbiol Infect Dis 1992;15(4 Suppl):123S-7S.
17. Biermann C, Loken A, Riise R. Comparison of spiramycin and doxycycline in the treatment of lower respiratory infections in general practice. J Antimicrob Chemother 1988;22(Suppl B):155-8.
18. Brumfitt W, Hamilton-Miller JM. Combinations of sulphonamides with diaminopyrimidines: how, when and why? J Chemother 1995;7(2):136-9.
19. Lacey RW, Lewis E. Is co-trimoxazole bactericidal in sputum? BMJ 1973;4(5885):165.
20. Grosset J, Bismuth R, Nguyen J. Pharmacokinetic basis for antibiotic therapy in broncho-pulmonary bacterial infections [in French]. Rev Fr Mal Respir 1982;10(3):195-203.
21. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57(9):759-64.
22. Reeves DS, Bint AJ, Bullock DW. Use of antibiotics. Sulphonamides, co-trimoxazole, and tetracyclines. BMJ 1978;2(6134):410-3.
23. Keisu M, Wiholm BE, Palmblad J. Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system. J Intern Med 1990;228(4):353-60.
24. Ekstrom B, Forsgren U, Ortengren B, Bergan T. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim. Infection 1979;7(Suppl 4):S359-66.
25. Hansen I, Lykkegaard Nielsen M, Bertelsen S. Trimethoprim in human saliva, bronchial secretion and lung tissue. Acta Pharmacol Toxicol (Copenh) 1973;32(5):337-44.
26. Sethi S. Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis 2005;41(Suppl 2):S177-85.